MEDICASURE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDICASURE
Largest movements
- Receivables within one year -€24,502
down €24,502 (-27.6%), from €88,737 to €64,236
- Intangible fixed assets -€3,601
down €3,601 (-29.1%), from €12,362 to €8,761
- Tangible fixed assets -€3,352
down €3,352 (-27.9%), from €11,999 to €8,647
of which Plant, machinery and equipment: -€3,250
- Trade debts -€22,926
no longer reported in 2024 (was €22,926)
- Profit (loss) carried forward -€8,872
down €8,872 (-5.0%), from -€176,675 to -€185,547
- Other operating charges -€17,638
down €17,638 (-97.2%), from €18,141 to €504
- Gross operating margin -€2,133
down €2,133, from €885 to -€1,248
- Financial charges -€867
down €867 (-83.8%), from €1,034 to €167
- Depreciation +€161
up €161 (+2.4%), from €6,792 to €6,953
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €133,296 | €101,245 | -€32,051 | -24.0% |
| Fixed assets | 21/28 | €24,361 | €17,408 | -€6,953 | -28.5% |
| Intangible fixed assets | 21 | €12,362 | €8,761 | -€3,601 | -29.1% |
| Tangible fixed assets | 22/27 | €11,999 | €8,647 | -€3,352 | -27.9% |
| Plant, machinery and equipment | 23 | €11,897 | €8,647 | -€3,250 | -27.3% |
| Furniture and vehicles | 24 | €102 | €0 | -€102 | -100% |
| Current assets | 29/58 | €108,935 | €83,837 | -€25,098 | -23.0% |
| Amounts receivable within one year | 40/41 | €88,737 | €64,236 | -€24,502 | -27.6% |
| Trade receivables | 40 | €88,737 | €64,236 | -€24,502 | -27.6% |
| Cash at bank and in hand | 54/58 | €13,223 | €13,264 | +€40 | +0.3% |
| Deferred charges and accrued income | 490/1 | €6,974 | €6,338 | -€636 | -9.1% |
| Total equity and liabilities | 10/49 | €133,296 | €101,245 | -€32,051 | -24.0% |
| Equity | 10/15 | -€5,075 | -€13,947 | -€8,872 | -175% |
| Contributions | 10/11 | €171,600 | €171,600 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€176,675 | -€185,547 | -€8,872 | -5.0% |
| Amounts payable | 17/49 | €138,371 | €115,192 | -€23,179 | -16.8% |
| Amounts payable within one year | 42/48 | €138,371 | €115,192 | -€23,179 | -16.8% |
| Current portion of amounts payable after more than one year | 42 | €428 | - | -€428 | |
| Trade debts | 44 | €22,926 | - | -€22,926 | |
| Suppliers | 440/4 | €22,926 | - | -€22,926 | |
| Taxes, remuneration and social security | 45 | €6,078 | €6,078 | = | 0.0% |
| Taxes | 450/3 | €1,878 | €1,878 | = | 0.0% |
| Remuneration and social security | 454/9 | €4,200 | €4,200 | = | 0.0% |
| Other amounts payable | 47/48 | €108,940 | €109,114 | +€174 | +0.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €6,792 | €6,953 | +€161 | +2.4% |
| Other operating charges | 640/8 | €18,141 | €504 | -€17,638 | -97.2% |
| Gross operating margin | 9900 | €885 | -€1,248 | -€2,133 | |
| Operating profit (loss) | 9901 | -€24,048 | -€8,704 | +€15,344 | +63.8% |
| Financial charges | 65/66B | €1,034 | €167 | -€867 | -83.8% |
| Recurring financial charges | 65 | €1,034 | €167 | -€867 | -83.8% |
| Profit (loss) for the period before taxes | 9903 | -€25,082 | -€8,872 | +€16,211 | +64.6% |
| Profit (loss) for the period | 9904 | -€25,082 | -€8,872 | +€16,211 | +64.6% |
| Profit (loss) for the period to be appropriated | 9905 | -€25,082 | -€8,872 | +€16,211 | +64.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.